Nitric oxide in diabetes mellitus

Journal of Hypertension

Volumn 21, Issue 6, 2003, Pages 1081-1083

  Tuck, Michael L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; NITRIC OXIDE; TETRAHYDROBIOPTERIN; TROGLITAZONE;

BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PLETHYSMOGRAPHY; PRIORITY JOURNAL;

EID: 0037527612     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200306000-00005     Document Type: Note

References (45)

1. Honing MLH, Morrison PJ, Banga JD, Stroes ESR, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabet Metabol Rev 1998; 14:241-249.
2. Stern N, Sowers J, Tuck M. Diabetes and hypertension. In: LeRoith D, Taylor S, Olefsky JM (editors): Diabetes mellitus: a fundamental text, 3rd edn. Philadelphia: Lippincott-Raven; 2003.
3. Kelm M. The L-arginine-nitric oxide pathway in hypertension. Curr Hypertens Rep 2003; 5:80-86.
4. Mäkimattila S, Yki-Järvinen H. Endothelial dysfunction in human diabetes. Curr Hypertens Rep 2002; 2:26-36.
5. Mäkimattila S, Virkamäki A, Groop P-H, Cockroft J, Utriainen T, Fogerudd J, Yki-Jarvinen H. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996; 94:1276-1282.
6. Tesfamarian B, Cohen R. Free radicals mediated endothelial cell dysfunction caused by elevated glucose. Am J Physiol Heart Circ Physiol 1992; 263:H321-H326.
7. Bucula R, Tracey KJ, Cerami A. Advanced glycosylation products quench NO and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 1991; 87:432-438.
8. Mayhan WG. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res 1992; 580:297-302.
9. Watts GF, O'Brien SF, Silvestor W, Millar JA. Impaired endothelium-dependent and independent dilation of forearm resistance arteries in men with diet-treated noninsulin-dependent diabetes: role of dyslipidemia. Clin Sci 1996; 91:567-573.
10. Mäkimattila S, Luoma JS, Ylä-Herttuala S, Bergholm R, Utriainen T, Virkami A, et al. Autoantibodies against oxidized LDL and endothelium-dependent vasodilation in insulin-dependent diabetes mellitus. Atherosclerosis 1999; 147:115-122.
11. Watts GF, Playford DA. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes: a hypothesis. Atherosclerosis 1998; 141:17-30.
12. O'Driscoll G, Green D, Rankin J, Stanton K, Taylor R. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997; 100:678-684.
13. Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin dependent diabetes mellitus. J Clin Invest 1996; 97:22-28.
14. Jensen JS, Feldt-Rasmussin B, Strandgard T, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and the risk of ischemic heart disease. Hypertension 2000; 35:898-903.
15. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90:2548-2554.
16. Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager MA. Impaired nitric oxide mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27:567-574.
17. Giugliano D, Paolisso G, Ceriello A. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19:257-267.
18. Ceriello A, Mercuri F, Quangliaro L, Assaloni R, Motz E, Tonutti L, et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001; 44:834-838.
19. Avogaro A, Piarulli F, Valerio A, Miola M, Calveri M, Pavan P, et al. Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes 1997; 46:1040-1046.
20. Hogikyan RV, Galecki AT, Pitt B, Halter JB, Greene DA, Supiano MA. Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. J Clin Endocrinol Metab 1998; 83:1946-1952.
21. Mäkimattila S, Liu M, Vakkilailnen J, Schlenzka A, Lahdenpera S, Syvanne M, et al. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 1999; 22:973-981.
22. Clealand SJ, Petrie JR, Small M, et al. Insulin action is associated with endothelial function in hypertension and type 2 diabetes. Hypertension 2000; 35:507-511.
23. Butler R, Morris AD, Belch JJF, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetes with mild hypertension. Hypertension 2000; 35:746-751.
24. Tan KCB, Ai VHG, Chow WS, Chau MT, Leong L, Lam KS. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 1999; 84:3212-3216.
25. Skyrme-Jones RA, O'Brien RC, Luo M, Meridith IT. Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes. J Am Coll Cardiol 2000; 35:292-322.
26. O'Driscoll G, Green D, Taylor RR. Simvostatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95:1126-1131.
27. Elliot TG, Crockcroft JR, Groop P-H, et al. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993; 85:687-693.
28. Jensen-Urstad KJ, Richard D, Rosfors JS, Lindblad LE, Jensen-Urstad MT. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 1996; 45:1253-1258.
29. Sowers JR. Hypertension, angiotensin II and oxidative stress. N Engl J Med 2002; 346:1999-2001.
30. Zeng G, Nystrom FH, Racichandran LV, Cong LN, Kirby M, Mostowski H, Ouon MJ. Roles for insulin signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000; 101:1539-1545.
31. Sowers JR, Lester M. Diabetes and cardiovascular disease. Diabetes Care 1999; 22:C14-C20.
32. Vehkavaara S, Seppala-Lindross A, Westerbacka J, Groop PH, Yki-Jarinen H. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care 1999; 22:2055-2060.
33. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-2610.
34. Balletshofer BM, Rettig K, Enderle MD, Volk A, Maerker E, Jacob S. Endothelial dysfunction is detectable in young normotensive first-degree relatives with type 2 diabetes in association with insulin resistance. Circulation 2000; 101:1780-1784.
35. Rodriguez-Mañas L, Lopez-Doriga P, Petidier R, et al. Effect of glycaemic control on the vascular nitric oxide system in patients with type 1 diabetes. J Hypertens 2003; 21:1137-1143.
36. The Diabetes Control and Complications Trials Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
37. Nagasaka S, Iwamoto Y, Ishikawa S, Kuzuya T, Saito T. Efficacy of troglitozone measured by insulin resistance index. Lancet 1997; 350:184.
38. Martin A, Foxall T, Blumberg JB, Meydani M. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler Thromb Vasc Biol 1997; 17:429-436.
39. Inoue S, Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 1995; 371:86-88.
40. Mancini GBH, Henry GC, Macya TJ, O'Neill BJ, Pucillo AL, Carere RG, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 94:258-265.
41. Chan NN, Chan CN. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in the insulin resistance syndrome? Diabetologia 2002; 45:1609-1616.
42. Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T, Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997; 99:41-46.
43. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PCKβ inhibitor. Science 1996; 272:728-731.
44. Alpert E, Gruzman A, Totary H, Kaiser N, Reich R, Sasson S. A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid. Biochem J 2002; 362:413-422.
45. Uhlmann S, Rezzoug K, Hoffman S, Weidmann P. Advanced glycation end products quench nitric oxide in vitro. Graefe's Arch Clin Opthalmol 2002; 240:860-866.